FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Juan José Lahuerta

Research Profile

Disorders

Multiple Myeloma

Procedures

Concepts & Ideas

Geographic Areas

Spain

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Margarita Blanes; Adrián Alegre; Joan Bladé; José D González; Juan José Lahuerta; Paz Ribas; Jesús F San Miguel; Miguel A Sanz; Carlos Solano; Javier de la Rubia
Intravenous busulfan and melphalan as a conditioning regimen for autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: a matched comparison to a melphalan-only approach.
Roberto J Pessoa de Magalhães; Monica Roig; Jesús F San Miguel; María-Belén Vidriales; Juan F Blanco; Elaine Sobral Costa; Javier de la Rubia; Natalia de las Heras; Carlos Fernandez-Gimenez; Ramón García-Sanz; Norma C Gutierrez; Jose Hernández; Juan José Lahuerta; Quentin Lecrevisse; Angelo Maiolino; Joaquin Martinez-Lopez; Maria V Mateos; Marcio Nucci; Enrique M Ocio; Alberto Orfao; Bruno Paiva; Martin Perez-Andres
Analysis of the immune system of multiple myeloma patients achieving long-term disease control by multidimensional flow cytometry.
Bruno Paiva; Luis Palomera; José J Pérez; Laura Rosiñol; Anna Sureda; María José Terol; María-Belén Vídriales; Adrian Alegre; Joan Bladé; Lourdes Cordón; Felipe de Arriba; Javier de la Rubia; Raquel De Paz; Joaquín Díaz-Mediavilla; María-Asunción Echeveste; Ana Gorosquieta; Norma C Gutiérrez; Juan José Lahuerta; Alejandro Martin; Joaquin Martinez-Lopez; María-Victoria Mateos; María-Ángeles Montalbán; Alberto Orfao; Albert Oriol; Jesús F San Miguel
Multiparameter flow cytometry evaluation of plasma cell DNA content and proliferation in 595 transplant-eligible patients with myeloma included in the Spanish GEM2000 and GEM2005<65y trials.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Juan José Lahuerta (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Margarita Blanes; Adrián Alegre; Joan Bladé; José D González; Juan José Lahuerta; Paz Ribas; Jesús F San Miguel; Miguel A Sanz; Carlos Solano; Javier de la Rubia
Intravenous busulfan and melphalan as a conditioning regimen for autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: a matched comparison to a melphalan-only approach.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(1):69-74.
2013: Roberto J Pessoa de Magalhães; Monica Roig; Jesús F San Miguel; María-Belén Vidriales; Juan F Blanco; Elaine Sobral Costa; Javier de la Rubia; Natalia de las Heras; Carlos Fernandez-Gimenez; Ramón García-Sanz; Norma C Gutierrez; Jose Hernández; Juan José Lahuerta; Quentin Lecrevisse; Angelo Maiolino; Joaquin Martinez-Lopez; Maria V Mateos; Marcio Nucci; Enrique M Ocio; Alberto Orfao; Bruno Paiva; Martin Perez-Andres
Analysis of the immune system of multiple myeloma patients achieving long-term disease control by multidimensional flow cytometry.
Haematologica 2013;98(1):79-86.
2012: Bruno Paiva; Luis Palomera; José J Pérez; Laura Rosiñol; Anna Sureda; María José Terol; María-Belén Vídriales; Adrian Alegre; Joan Bladé; Lourdes Cordón; Felipe de Arriba; Javier de la Rubia; Raquel De Paz; Joaquín Díaz-Mediavilla; María-Asunción Echeveste; Ana Gorosquieta; Norma C Gutiérrez; Juan José Lahuerta; Alejandro Martin; Joaquin Martinez-Lopez; María-Victoria Mateos; María-Ángeles Montalbán; Alberto Orfao; Albert Oriol; Jesús F San Miguel
Multiparameter flow cytometry evaluation of plasma cell DNA content and proliferation in 595 transplant-eligible patients with myeloma included in the Spanish GEM2000 and GEM2005<65y trials.
The American journal of pathology 2012;181(5):1870-8.
2012: Maria V Mateos; Albert Oriol; Luis Palomera; Francisco-Javier Peñalver; Montserrat Pérez; Marta Polo; José-María Ribera; Joan Bargay; José-Luis Bello; Enrique Bengoechea; Joan Bladé; Felipe de Arriba; Ramón García-Sanz; Yolanda González; Miquel Granell; Norma C Gutiérrez; Jose-Mariano Hernández; Juan José Lahuerta; Ana López de la Guía; Javier López; Joaquin Martinez-Lopez; María-Luisa Martín-Mateos; Ana-Isabel Teruel; Jesús F San Miguel
Maintenance therapy with bortezomib plus thalidomide or bortezomib plus prednisone in elderly multiple myeloma patients included in the GEM2005MAS65 trial.
Blood 2012;120(13):2581-8.
2012: Lucía López-Corral; Maria V Mateos; Jesús F San Miguel; María Eugenia Sarasquete; Luis A Corchete; Felipe de Arriba; Javier de la Rubia; Ramón García-Sanz; Juan José Lahuerta; Norma C Gutiérrez
Genomic analysis of high-risk smoldering multiple myeloma.
Haematologica 2012;97(9):1439-43.
2012: Laura Rosiñol; Jesús San Miguel; Ana Isabel Teruel; Adrián Alegre; Joan Besalduch; Joan Bladé; M Teresa Cibeira; Felipe de Arriba; Javier de la Rubia; Joaquín Díaz-Mediavilla; María Asunción Etxebeste; Yolanda González; Miquel Granell; Norma C Gutiérrez; Dolores Hernández; Miguel T Hernández; Juan José Lahuerta; Javier López-Jiménez; Joaquín Martínez; María Luisa Martín-Ramos; Maria V Mateos; Albert Oriol; Luis Palomera
Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM study.
Blood 2012;120(8):1589-96.
2012: Bruno Paiva; L Palomera; Atanasio Pandiella; José J Pérez; L Rosiñol; M-J Terol; M-B Vídriales; E Bengoechea; Joan Bladé; X Chen; Felipe de Arriba; R de Paz; Elena Diaz-Rodriguez; E Fernández-Redondo; Norma C Gutiérrez; J Hernández; Juan José Lahuerta; L López-Corral; A Martin; Joaquin Martinez-Lopez; Maria V Mateos; J F San Miguel; M-Á Montalbán; Alberto Orfao; A Oriol
Clinical significance of CD81 expression by clonal plasma cells in high-risk smoldering and symptomatic multiple myeloma patients.
Leukemia 2012;26(8):1862-9.
2012: Laura Rosiñol; Jesús San Miguel; Adrián Alegre; Joan Besalduch; Joan Bladé; Javier de la Rubia; Joaquín Díaz-Mediavilla; Juan Carlos García-Ruiz; Ramón García-Sanz; Santiago Gardella; Miquel Granell; Miguel Hernández-García; Belén Hernández-Ruiz; Juan José Lahuerta; Javier López Jiménez; Isabel Navarro; Albert Oriol; Chelo Rayón
Benefit from autologous stem cell transplantation in primary refractory myeloma? Different outcomes in progressive versus stable disease.
Haematologica 2012;97(4):616-21.
2012: Bruno Paiva; Luis Palomera; Laura Rosiñol; Jesús F San Miguel; Anna Sureda; María José Terol; María-Belén Vídriales; Adrián Alegre; Joan Bladé; M Teresa Cibeira; Lourdes Cordón; Felipe de Arriba; Javier de la Rubia; Raquel de Paz; Joaquín Díaz-Mediavilla; María-Asunción Echeveste; Ana Gorosquieta; Norma C Gutiérrez; Miguel T Hernández; Juan José Lahuerta; Alejandro Martin; Joaquin Martinez-Lopez; Maria V Mateos; María-Ángeles Montalbán; Albert Oriol
High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myeloma.
Blood 2012;119(3):687-91.
2011: María-Victoria Mateos; María-Angeles Montalbán; Albert Oriol; Bruno Paiva; Luis Palomera; Francisco-Javier Peñalver; Josep-Maria Ribera; Joan Bargay; Enrique Bengoechea; Joan Bladé; Felipe de Arriba; Joaquín Díaz-Mediavilla; Manuela Fernández; Ramón García-Sanz; Norma C Gutiérrez; José-Mariano Hernández; Juan José Lahuerta; Alejandro Martín; Joaquin Martinez-Lopez; María-Luisa Martín-Mateos; María-Luisa Martín-Ramos; Anna Sureda; Ana-Isabel Teruel; María-Belén Vidriales; Jesús F San Miguel
Outcome according to cytogenetic abnormalities and DNA ploidy in myeloma patients receiving short induction with weekly bortezomib followed by maintenance.
Blood 2011;118(17):4547-53.
2011: Joaquin Martinez-Lopez; María-Victoria Mateos; José María Moraleda; Jesús San Miguel; Anna Sureda; Maria C Viguria; Adrián Alegre; Joan Besalduch; Joan Blade; Rafael Cabrera; Eulogio Conde; Felipe de Arriba; Javier de la Rubia; José García-Laraña; Juan Carlos García-Ruiz; Maria Carmen Gomez del Castillo; José D Gonzalez-San Miguel; Carlos Grande; José Luis Guzman-Zamudio; Juan José Lahuerta; Rafael Martinez
Long-term prognostic significance of response in multiple myeloma after stem cell transplantation.
Blood 2011;118(3):529-34.
2011: Bruno Paiva; Joaquin Martinez-Lopez; María-Belén Vidriales; Maria-Victoria Mateos; Maria-Angeles Montalban; Elena Fernandez-Redondo; Lourdes Alonso; Albert Oriol; Ana-Isabel Teruel; Raquel de Paz; José-Garcia Laraña; Enrique Bengoechea; Alejandro Martin; Joaquin Diaz Mediavilla; Luis Palomera; Felipe de Arriba; Joan Bladé; Alberto Orfao; Juan José Lahuerta; Jesus F San Miguel
Comparison of immunofixation, serum free light chain, and immunophenotyping for response evaluation and prognostication in multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(12):1627-33.
2011: Bruno Paiva; M Pérez-Andrés; M-B Vídriales; Julia Almeida; N de las Heras; Maria V Mateos; L López-Corral; Norma C Gutiérrez; J Blanco; A Oriol; M T Hernández; F de Arriba; A G de Coca; M-J Terol; Javier de la Rubia; Y González; A Martín; Anna Sureda; M Schmidt-Hieber; Alexander Schmitz; H E Johnsen; Juan José Lahuerta; Joan Bladé; Jesús F San Miguel; Alberto Orfao
Competition between clonal plasma cells and normal cells for potentially overlapping bone marrow niches is associated with a progressively altered cellular distribution in MGUS vs myeloma.
Leukemia 2011;25(4):697-706.
2011: Adrián Alegre; Beatriz Aguado; Pilar Giraldo; Eduardo Ríos; Araceli Cánovas; Angela Ibáñez; Inmaculada Castillo; Miguel T Hernández; Albert Oriol; Luis Palomera; Juan-N Rodríguez; Flor-L García; José M Calvo; Carmen Martínez-Chamorro; Javier de la Serna; Juan José Lahuerta
Lenalidomide is effective as salvage therapy in refractory or relapsed multiple myeloma: analysis of the Spanish Compassionate Use Registry in advanced patients.
International journal of hematology 2011;93(3):351-60.
2010: Juan José Lahuerta; Maria Victoria Mateos; Joaquin Martínez-López; Carlos Grande; Javier de la Rubia; Laura Rosiñol; Anna Sureda; José García-Laraña; Joaquín Díaz-Mediavilla; Miguel T Hernández-García; Dolores Carrera; Joan Besalduch; Felipe de Arriba; Albert Oriol; Lourdes Escoda; Javier García-Frade; Concepción Rivas-González; Adrián Alegre; Joan Bladé; Jesús F San Miguel
Busulfan 12 mg/kg plus melphalan 140 mg/m2 versus melphalan 200 mg/m2 as conditioning regimens for autologous transplantation in newly diagnosed multiple myeloma patients included in the PETHEMA/GEM2000 study.
Haematologica 2010;95(11):1913-20.
2010: María-Victoria Mateos; Albert Oriol; Joaquín Martínez-López; Norma Gutiérrez; Ana-Isabel Teruel; Raquel de Paz; José García-Laraña; Enrique Bengoechea; Alejandro Martín; Joaquín Díaz Mediavilla; Luis Palomera; Felipe de Arriba; Yolanda González; Jose-Mariano Hernández; Ana Sureda; José-Luis Bello; Joan Bargay; Francisco-Javier Peñalver; José-María Ribera; María-Luisa Martín-Mateos; Ramón García-Sanz; María-Teresa Cibeira; María-Luisa Martín Ramos; María-Belén Vidriales; Bruno Paiva; María-Angeles Montalbán; Juan José Lahuerta; Joan Bladé; Jesús-Fernando San Miguel
Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial.
The lancet oncology 2010;11(10):934-41.
2010: María Victoria Mateos; Maria Teresa Cibeira; Paul G Richardson; Felipe Prosper; Albert Oriol; Javier de la Rubia; Juan José Lahuerta; Ramón García-Sanz; Sonia Extremera; Sergio Szyldergemajn; Claudia Corrado; Harald Singer; Constantine S Mitsiades; Kenneth C Anderson; Joan Bladé; Jesús San Miguel
Phase II clinical and pharmacokinetic study of plitidepsin 3-hour infusion every two weeks alone or with dexamethasone in relapsed and refractory multiple myeloma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(12):3260-9.
2010: Ramón García-Sanz; Adrián Alegre; Francisco Javier Capote; José Mariano Hernández; Laura Rosiñol; Javier de la Rubia; Anna Sureda; Felipe de Arriba; Joan Bargay; Joaquín Díaz-Mediavilla; José García-Laraña; Juan José Lahuerta; Maria V Mateos; Felipe Prósper; Jesús San Miguel; Joan Bladé
[Guidelines for the use of bisphosphonates in multiple myeloma: Recommendations of the expert committee of the Spanish Myeloma Group from the PETHEMA group].
Medicina clínica 2010;134(6):268-78.
2009: Bruno Paiva; Maria-Belén Vidriales; Gema Mateo; Jose J Pérez; Maria Angeles Montalbán; Anna Sureda; Laura Montejano; Norma C Gutiérrez; Alfonso García de Coca; Natalia de las Heras; Maria Victoria Mateos; Maria Consuelo López-Berges; Raimundo García-Boyero; Josefina Galende; Jose Hernández; Luis Palomera; Dolores Carrera; Rafael Martínez; Javier de la Rubia; Alejandro Martín; Yolanda González; Joan Bladé; Juan José Lahuerta; Alberto Orfao; Jesús F San Miguel
The persistence of immunophenotypically normal residual bone marrow plasma cells at diagnosis identifies a good prognostic subgroup of symptomatic multiple myeloma patients.
Blood 2009;114(20):4369-72.
2009: Francesc Valldeoriola; S Cobaleda; Juan José Lahuerta
A multicentre retrospective study of the clinical use of ropinirole in the treatment of Parkinson's disease: the ROPI-PARK study.
Clinical neurology and neurosurgery 2009;111(9):742-7.
2009: Javier de la Rubia; Pau Montesinos; Rodrigo Martino; Isidro Jarque; Montserrat Rovira; Lourdes Vázquez; Javier López; Montserrat Batlle; Rafael de La Cámara; Antoni Juliá; Juan José Lahuerta; Guillermo Deben; Joaquin Díaz; Raimundo García; Miguel A Sanz
Imipenem/cilastatin with or without glycopeptide as initial antibiotic therapy for recipients of autologous stem cell transplantation: results of a Spanish multicenter study.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(4):512-6.
2009: Margarita Blanes; Javier de la Rubia; Juan José Lahuerta; José D González; Paz Ribas; Carlos Solano; Adrián Alegre; Miguel A Sanz
Single daily dose of intravenous busulfan and melphalan as a conditioning regimen for patients with multiple myeloma undergoing autologous stem cell transplantation: a phase II trial.
Leukemia & lymphoma 2009;50(2):216-22.
2008: Juan José Lahuerta; Maria Victoria Mateos; Joaquin Martínez-López; Laura Rosiñol; Anna Sureda; Javier de la Rubia; José García-Laraña; Rafael Martínez-Martínez; Miguel T Hernández-García; Dolores Carrera; Joan Besalduch; Felipe de Arriba; Josep-Maria Ribera; Lourdes Escoda; Belén Hernández-Ruiz; Javier García Frade; Concepción Rivas-González; Adrián Alegre; Joan Bladé; Jesús F San Miguel
Influence of pre- and post-transplantation responses on outcome of patients with multiple myeloma: sequential improvement of response and achievement of complete response are associated with longer survival.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(35):5775-82.
2008: Laura Rosiñol; José A Pérez-Simón; Anna Sureda; Javier de la Rubia; Felipe de Arriba; Juan José Lahuerta; José David González; Joaquín Díaz-Mediavilla; Belén Hernández; Javier García Frade; Dolores Carrera; Angel León; Miguel Hernández; Pascual Fernández Abellán; Juan Miguel Bergua; Jesús San Miguel; Joan Bladé
A prospective PETHEMA study of tandem autologous transplantation versus autograft followed by reduced-intensity conditioning allogeneic transplantation in newly diagnosed multiple myeloma.
Blood 2008;112(9):3591-3.
2008: Francis Ayuk; Jose A Perez-Simon; Avichai Shimoni; Anna Sureda; Tatjana Zabelina; Rainer Schwerdtfeger; Rodrigo Martino; Herbert G Sayer; Adrián Alegre; Juan José Lahuerta; Djordje Atanackovic; Christine Wolschke; Arnon Nagler; Axel R Zander; Jesús F San Miguel; Nicolaus Kröger
Clinical impact of human Jurkat T-cell-line-derived antithymocyte globulin in multiple myeloma patients undergoing allogeneic stem cell transplantation.
Haematologica 2008;93(9):1343-50.
2008: Pilar Martínez-Sánchez; Laura Montejano; María Eugenia Sarasquete; Ramón García-Sanz; Elena Fernández-Redondo; ROSA AYALA; María Angeles Montalbán; Rafael Martínez; José García-Laraña; Adrián Alegre; Belen Hernández; Juan José Lahuerta; Joaquin Martinez-Lopez
Evaluation of minimal residual disease in multiple myeloma patients by fluorescent-polymerase chain reaction: the prognostic impact of achieving molecular response.
British journal of haematology 2008;142(5):766-74.
2008: José Rodríguez; Eulogio Conde; Antonio Gutiérrez; Juan Carlos García; Juan José Lahuerta; María Rosario Varela; Catalina Pérez; Carmen Albo; María Dolores Caballero
Primary mediastinal large cell lymphoma (PMBL): frontline treatment with autologous stem cell transplantation (ASCT). The GEL-TAMO experience.
Hematological oncology 2008;26(3):171-8.
2008: Reyes Arranz; Eulogio Conde; Carlos Grande; Maria Victoria Mateos; Marcos Gandarillas; Carmen Albo; Juan José Lahuerta; José María Fernández-Rañada; Miguel T Hernández; Natalia Alonso; José A García Vela; Sebastián Garzón; José Rodríguez; Dolores Caballero
Dose-escalated CHOP and tailored intensification with IFE according to early response and followed by BEAM/autologous stem-cell transplantation in poor-risk aggressive B-cell lymphoma: a prospective study from the GEL-TAMO Study Group.
European journal of haematology 2008;80(3):227-35.
2007: Enric Carreras; Laura Rosiñol; María José Terol; Adrián Alegre; Felipe de Arriba; José García-Laraña; José Luis Bello; Raimundo García; Angel León; Rafael Martínez; M Jesús Peñarrubia; Concha Poderós; Paz Ribas; Josep-Maria Ribera; Jesús San Miguel; Joan Bladé; Juan José Lahuerta
Veno-occlusive disease of the liver after high-dose cytoreductive therapy with busulfan and melphalan for autologous blood stem cell transplantation in multiple myeloma patients.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(12):1448-54.
2007: Laura Rosiñol; Albert Oriol; Maria V Mateos; Anna Sureda; Pedro García-Sánchez; Norma C Gutiérrez; Adrián Alegre; Juan José Lahuerta; Javier de la Rubia; Carlos Herrero; Xiangyang Liu; Helgi Van de Velde; Jesús San Miguel; Joan Bladé
Phase II PETHEMA trial of alternating bortezomib and dexamethasone as induction regimen before autologous stem-cell transplantation in younger patients with multiple myeloma: efficacy and clinical implications of tumor response kinetics.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(28):4452-8.
2007: José Bagán; Juan Blade; Jose Manuel Cozar; Manuel Constela; Ramón García-Sanz; Francisco Gómez Veiga; Juan José Lahuerta; Ana Lluch; Bartomeu Massuti; Juan Morote; Jesús F San Miguel; Eduardo Solsona
Recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw (ONJ) in cancer patients treated with bisphosphonates.
Medicina oral, patología oral y cirugía bucal 2007;12(4):E336-40.
2007: José Rodríguez; Eulogio Conde; Antonio Gutiérrez; Juan José Lahuerta; Reyes Arranz; Anna Sureda; Javier Zuazu; Alberto Fernández de Sevilla; Maurizio Bendandi; Carlos Solano; Angel León; María Rosario Varela; María Dolores Caballero
The adjusted International Prognostic Index and beta-2-microglobulin predict the outcome after autologous stem cell transplantation in relapsing/refractory peripheral T-cell lymphoma.
Haematologica 2007;92(8):1067-74.
2007: Guillermo Garcia-Effron; S Gamarra; A Crooke; P Martínez-Sánchez; Juan José Lahuerta; J Martínez-López
Comparison of the MagNA pure LC automated system and the RiboPure-Blood RNA manual method for RNA extraction from multiple myeloma bone marrow samples conserved in an RNA stabilizer.
International journal of laboratory hematology 2007;29(2):139-44.
2007: Norma C Gutiérrez; Mariana Castellanos; M Luisa Martín; Maria V Mateos; Jesús M Hernández; M Fernández; Dolores Carrera; Laura Rosiñol; Josep-Maria Ribera; J M Ojanguren; Luis Palomera; Santiago Gardella; Lourdes Escoda; J C Hernández-Boluda; J L Bello; Javier de la Rubia; Juan José Lahuerta; Jesús F San Miguel
Prognostic and biological implications of genetic abnormalities in multiple myeloma undergoing autologous stem cell transplantation: t(4;14) is the most relevant adverse prognostic factor, whereas RB deletion as a unique abnormality is not associated with adverse prognosis.
Leukemia 2007;21(1):143-50.
2006: Maria V Mateos; Jesús M Hernández; Miguel-T Hernández; Norma C Gutiérrez; Luis Palomera; Marta Fuertes; Joaquín Díaz-Mediavilla; Juan José Lahuerta; Javier de la Rubia; María José Terol; Anna Sureda; Joan Bargay; Paz Ribas; Felipe de Arriba; Adrián Alegre; Albert Oriol; Dolores Carrera; José García-Laraña; Ramón García-Sanz; Joan Bladé; Felipe Prósper; Gema Mateo; Dixie Esseltine; Helgi van de Velde; Jesús F San Miguel
Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: results of a multicenter phase 1/2 study.
Blood 2006;108(7):2165-72.
2006: Joaquin Martinez-Lopez; Pilar Martinez-Sanchez; Ramon Garcia-Sanz; Maria Eugenia Sarasquete; ROSA AYALA; Marcos Gonzalez; Jose Manuel Bautista; David Gonzalez; Jesús San Miguel; Guillermo Garcia-Effron; Juan José Lahuerta
Application of self-quenched JH consensus primers for real-time quantitative PCR of IGH gene to minimal residual disease evaluation in multiple myeloma.
The Journal of molecular diagnostics : JMD 2006;8(3):364-70.
2006: Javier de la Rubia; Joan Bladé; Juan José Lahuerta; Josep-Maria Ribera; Rafael Martínez; Adrián Alegre; José García-Laraña; Pascual Fernández; Anna Sureda; Felipe de Arriba; Dolores Carrera; Joan Besalduch; Raimundo García-Boyero; Luis Palomera Bernal; Miguel T Hernández; Paz Ribas García; Javier Pérez-Calvo; Antonio Alcalá; Luis Felipe Casado; Jesús San Miguel
Effect of chemotherapy with alkylating agents on the yield of CD34+ cells in patients with multiple myeloma. Results of the Spanish Myeloma Group (GEM) Study.
Haematologica 2006;91(5):621-7.
2006: José A Pérez-Simón; A Sureda; F Fernández-Aviles; A Sampol; José Rafael Cabrera; Dolores Caballero; Rodrigo Martino; J Petit; José F Tomás; José María Moraleda; Adrián Alegre; Consuelo Cañizo; Salut Brunet; Laura Rosiñol; Juan José Lahuerta; José L Díez-Martín; A León; A García; Lourdes Vazquez; Jorge Sierra; Jesús F San Miguel
Reduced-intensity conditioning allogeneic transplantation is associated with a high incidence of extramedullary relapses in multiple myeloma patients.
Leukemia 2006;20(3):542-5.
2005: María Eugenia Sarasquete; Ramón García-Sanz; David González; Joaquín Martínez; Gema Mateo; Pilar Martínez; José Maria Ribera; Jesús M Hernández; Juan José Lahuerta; Alberto Orfão; Marcos González; Jesús F San Miguel
Minimal residual disease monitoring in multiple myeloma: a comparison between allelic-specific oligonucleotide real-time quantitative polymerase chain reaction and flow cytometry.
Haematologica 2005;90(10):1365-72.
2005: Philip R Greipp; Jesús San Miguel; Brian G M Durie; John J Crowley; Bart Barlogie; Joan Bladé; Mario Boccadoro; J Anthony Child; Hervé Avet-Loiseau; Jean-Luc Harousseau; Robert A Kyle; Juan José Lahuerta; Heinz Ludwig; Gareth Morgan; Raymond Powles; Kazuyuki Shimizu; Chaim Shustik; Pieter Sonneveld; Patrizia Tosi; Ingemar Turesson; Jan Westin
International staging system for multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(15):3412-20.
2005: Gema Mateo; Mariana Castellanos; Ana Rasillo; Norma C Gutiérrez; Maria A Montalbán; M Luisa Martín; Jesús Ma Hernández; Ma Consuelo López-Berges; Laura Montejano; Joan Bladé; Maria V Mateos; Anna Sureda; Javier de la Rubia; Joaquín Díaz-Mediavilla; Atanasio Pandiella; Juan José Lahuerta; Alberto Orfao; Jesús F San Miguel
Genetic abnormalities and patterns of antigenic expression in multiple myeloma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(10):3661-7.
2005: Anna Sureda; M Constans; Arturo Iriondo; Reyes Arranz; María Dolores Caballero; María J Vidal; J Petit; A López; Juan José Lahuerta; Enric Carreras; Javier García Conde; José García-Laraña; Rafael Cabrera; Isidro Jarque; Dolores Carrera; Juan Carlos García-Ruiz; Maria-Jesus Pascual; J Rifón; José María Moraleda; Katty Pérez-Equiza; Carmen Albó; Joaquín Díaz-Mediavilla; Antonio Torres; P Torres; Joan Besalduch; Julián Marín; Maria V Mateos; José María Fernández-Rañada; Jorge Sierra; Eulogio Conde
Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin's lymphoma autografted after a first relapse.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(4):625-33.
2004: J Rodriguez; María Dolores Caballero; A Gutierrez; Carlos Solano; Reyes Arranz; Juan José Lahuerta; Jorge Sierra; Marcos Gandarillas; Jose A Perez-Simon; Javier Zuazu; Armando Lopez-Guillermo; Anna Sureda; Enric Carreras; J Garcia-Laraña; J Marin; J C Garcia; A Fernandez De Sevilla; J Rifon; R Varela; Isidro Jarque; Carmen Albo; Angel Leon; J SanMiguel; Eulogio Conde
Autologous stem-cell transplantation in diffuse large B-cell non-Hodgkin's lymphoma not achieving complete response after induction chemotherapy: the GEL/TAMO experience.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(10):1504-9.
2004: Joaquin Martinez-Lopez; Juan José Lahuerta; P Salama; ROSA AYALA; J M Bautista
The use of fluorescent molecular beacons in real time PCR of IgH gene rearrangements for quantitative evaluation of multiple myeloma.
Clinical and laboratory haematology 2004;26(1):31-5.
2003: José Rodríguez; María Dolores Caballero; Antonio Gutiérrez; Julián Marín; Juan José Lahuerta; Anna Sureda; Enric Carreras; Angel León; Reyes Arranz; Alberto Fernández de Sevilla; Javier Zuazu; José García-Laraña; J Rifon; R Varela; Marcos Gandarillas; J SanMiguel; Eulogio Conde
High-dose chemotherapy and autologous stem cell transplantation in peripheral T-cell lymphoma: the GEL-TAMO experience.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(12):1768-75.
2003: Jesús García; Manuel Lizasoain; Juan José Lahuerta; Francisca Sanz
[Bacteremia due to Capnocytophaga spp.: two cases].
Enfermedades infecciosas y microbiología clínica 2003;21(3):168-9.
2003: Juan José Lahuerta; Carlos Grande; Joaquín Martínez-Lopez; Javier de la Serna; Rosa Toscano; María Cruz Ortiz; Santiago Larregla; Eulogio Conde; Andrés Insunza; José David Gonzalez-San Miguel; Joan Bargay; Rafael Cabrera; Juan Carlos García-Ruiz; Carmen Albó; Luis García-Alonso; Fernando Solano; Pilar Vivancos; Angel León; Jesús San Miguel
Tandem transplants with different high-dose regimens improve the complete remission rates in multiple myeloma. Results of a Grupo Español de Síndromes Linfoproliferativos/Trasplante Autólogo de Médula Osea phase II trial.
British journal of haematology 2003;120(2):296-303.
2003: María Dolores Caballero; José A Pérez-Simón; Arturo Iriondo; Juan José Lahuerta; Jorge Sierra; Julián Marín; Marcos Gandarillas; Reyes Arranz; Javier Zuazu; V Rubio; Alberto Fernández de Sevilla; Enric Carreras; Javier García Conde; José García-Laraña; Carlos Grande; Anna Sureda; María J Vidal; J Rifón; C Pérez-Equiza; R Varela; José María Moraleda; J C García Ruíz; Carmen Albó; Rafael Cabrera; Jesús F San Miguel; Eulogio Conde
High-dose therapy in diffuse large cell lymphoma: results and prognostic factors in 452 patients from the GEL-TAMO Spanish Cooperative Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(1):140-51.
2002: Miguel A Sanz; Javier López; Juan José Lahuerta; Montserrat Rovira; Montserrat Batlle; Cristina Pérez; Lourdes Vázquez; Antonio Julià; Javier Palau; Martín Gutiérrez; Francisco J Capote; Fernando Ramos; Luis Benlloch; Luis Larrea; Isidro Jarque
Cefepime plus amikacin versus piperacillin-tazobactam plus amikacin for initial antibiotic therapy in haematology patients with febrile neutropenia: results of an open, randomized, multicentre trial.
The Journal of antimicrobial chemotherapy 2002;50(1):79-88.
2002: Adrián Alegre; Asunción Granda; Carmen Martínez-Chamorro; Joaquín Díaz-Mediavilla; Rafael Martínez; José García-Laraña; Juan José Lahuerta; Anna Sureda; Joan Bladé; Javier de la Rubia; José María Fernández-Rañada; Jesús San Miguel
Different patterns of relapse after autologous peripheral blood stem cell transplantation in multiple myeloma: clinical results of 280 cases from the Spanish Registry.
Haematologica 2002;87(6):609-14.
2002: Juan José Lahuerta; Carlos Grande; Joan Blade; Joaquin Martinez-Lopez; Javier de la Serna; Adrián Alegre; Laraña Jose Garcia; Dolores Caballero; Javier de la Rubia; Julián Marín; Cristina Perez-Lopez; Anna Sureda; Antonio Escudero; Rafael Cabrera; Eulogio Conde; Juan Carlos García-Ruiz; Katty Pérez-Equiza; Fernado Hernandez; Luis Palomera; Angel León; Pilar Giraldo; Carlos Solano; Joan Bargay; Miguel Jesús San
Myeloablative treatments for multiple myeloma: update of a comparative study of different regimens used in patients from the Spanish registry for transplantation in multiple myeloma.
Leukemia & lymphoma 2002;43(1):67-74.
2001: Anna Sureda; Reyes Arranz; Arturo Iriondo; Enric Carreras; Juan José Lahuerta; Javier García Conde; Isidro Jarque; María Dolores Caballero; C Ferrà; A López; José García-Laraña; Rafael Cabrera; Dolores Carrera; M D Ruiz-Romero; Angel León; J Rifón; Joaquín Díaz-Mediavilla; R Mataix; M Morey; José María Moraleda; Albert Altés; Armando López-Guillermo; Javier de la Serna; José María Fernández-Rañada; Jorge Sierra; Eulogio Conde
Autologous stem-cell transplantation for Hodgkin's disease: results and prognostic factors in 494 patients from the Grupo Español de Linfomas/Transplante Autólogo de Médula Osea Spanish Cooperative Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(5):1395-404.
2001: Antonio Salar; Jorge Sierra; Marcos Gandarillas; María Dolores Caballero; Julián Marín; Juan José Lahuerta; Javier García Conde; Reyes Arranz; Angel León; Javier Zuazu; José García-Laraña; Armando López-Guillermo; Miguel A Sanz; Albert Grañena; J C García; Eulogio Conde
Autologous stem cell transplantation for clinically aggressive non-Hodgkin's lymphoma: the role of preparative regimens.
Bone marrow transplantation 2001;27(4):405-12.
2000: Juan José Lahuerta; Joaquin Martinez-Lopez; J D Serna; Joan Bladé; Carlos Grande; Adrián Alegre; L Vazquez; José García-Laraña; Anna Sureda; J D Rubia; Eulogio Conde; R Martinez; K Perez-Equiza; José María Moraleda; Angel León; Joan Besalduch; Rafael Cabrera; J D Miguel; A Morales; J C García-Ruíz; J Diaz-Mediavilla; Jesús San Miguel
Remission status defined by immunofixation vs. electrophoresis after autologous transplantation has a major impact on the outcome of multiple myeloma patients.
British journal of haematology 2000;109(2):438-46.
2000: Juan José Lahuerta; Joaquin Martinez-Lopez; Carlos Grande; Joan Bladé; Javier de la Serna; Adrián Alegre; José García-Laraña; Dolores Caballero; Anna Sureda; Javier de la Rubia; A M Alvarez; Julián Marín; Antonio Escudero; Eulogio Conde; K Perez-Equiza; Juan Carlos García-Ruiz; José María Moraleda; Angel León; Joan Bargay; Rafael Cabrera; M T Hernandez-García; J Diaz-Mediavilla; J S Miguel
Conditioning regimens in autologous stem cell transplantation for multiple myeloma: a comparative study of efficacy and toxicity from the Spanish Registry for Transplantation in Multiple Myeloma.
British journal of haematology 2000;109(1):138-47.
1999: Carolina Ibarrola de Andrés; Rosa Toscano; Juan José Lahuerta; M A Martínez-González
Simultaneous occurrence of Hodgkin's disease, nodal Langerhans' cell histiocytosis and multiple myeloma IgA(kappa).
Virchows Archiv : an international journal of pathology 1999;434(3):259-62.
1998: Rocio Garcia-Carbonero; Luis Paz-Ares; Alberto Arcediano; Juan José Lahuerta; A Bartolome; Hernán Cortes-Funes
Favorable prognosis after late relapse of Hodgkin's disease.
Cancer 1998;83(3):560-5.
1998: Adrián Alegre; Joaquín Díaz-Mediavilla; Jesús San Miguel; Rafael Martínez; José García-Laraña; Anna Sureda; Juan José Lahuerta; D Morales; Joan Bladé; Dolores Caballero; Javier de la Rubia; Antonio Escudero; José L Díez-Martín; Fernando Hernández-Navarro; J Rifón; Jesús Odriozola; Salut Brunet; Javier de la Serna; Joan Besalduch; María J Vidal; Carlos Solano; A Leon; J J Sánchez; Carmen Martínez-Chamorro; José María Fernández-Rañada
Autologous peripheral blood stem cell transplantation for multiple myeloma: a report of 259 cases from the Spanish Registry. Spanish Registry for Transplant in MM (Grupo Español de Trasplante Hematopoyético-GETH) and PETHEMA.
Bone marrow transplantation 1998;21(2):133-40.
1997: Anna Sureda; R Mataix; Fernando Hernández-Navarro; Isidro Jarque; Juan José Lahuerta; José F Tomás; Salut Brunet; Dolores Caballero; Eulogio Conde; Angel León; Manuel-Nicolás Fernández; A López; Juan Maldonado; E Bengoechea; M Callís; Dolores Carrera; Javier García Conde; José García-Laraña; José María Moraleda; M Morey; J Rifón; Jorge Sierra; Antonio Torres; A Domingo-Albós
Autologous stem cell transplantation for poor prognosis Hodgkin's disease in first complete remission: a retrospective study from the Spanish GEL-TAMO cooperative group.
Bone marrow transplantation 1997;20(4):283-8.
1997: José García-Laraña; Joaquín Díaz-Mediavilla; R Martínez; Juan José Lahuerta; Adrián Alegre; Jesús Odriozola; A Sureda; Jesús San Miguel; Javier de la Rubia; A Escudero; Eulogio Conde; J Bladé; R Cabrera; J Gastearena; Joan Besalduch; María J Vidal; F Hernández; J Rifon; A Leon; R Mataix; Ricardo Parody; José María Moraleda; Carlos Solano; J M de Pablos; J J Sánchez
[Maintenance treatment with interferon-alfa in multiple myeloma after autotransplantation of peripheral blood progenitor cells. Spanish Register of Transplantation in Myeloma].
Sangre 1997;42 Suppl 1():38-41.
1997: Luis Paz-Ares; Juan José Lahuerta; A Montes
[The intensive treatment of multiple myeloma with support from hematopoietic progenitors].
Medicina clínica 1997;108(6):226-9.
1980: José María Fernández-Rañada; Lourdes Vázquez; A Escudero; J L Merino; F Gómez-Reino; F Olmeda; Juan José Lahuerta; S Larregla
[Sulphatrimethoprim-nystatin combination in the prophylaxis of infection in acute leukaemia (author's transl)].
Sangre 1980;25(4):461-5.